COMPOSICIONES Y PREPARACIONES COMBINADAS DE SUNITINIB Y L-CARNITINA

摘要

The invention relates to a combined pharmaceutical composition and preparation that includes Sunitinib and L-carnitine, for use in the treatment of renal cell carcinoma, gastrointestinal stromal tumors and solid tumors, in particular breast, lung and colorectal cancer.